L
LG CNS Co Ltd
KRX:064400
LG CNS Co Ltd
KRX:064400
Price:
57 600
KRW
1.95%
Market Closed
Market Cap:
₩5.6T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
LG CNS Co Ltd
KRX:064400
|
KR |
|
P
|
Prism Finance Ltd
BSE:531735
|
IN |
|
V
|
Viet Tri Chemical JSC
VN:HVT
|
VN |
|
Medipal Holdings Corp
TSE:7459
|
JP |
|
E
|
Endurance Technologies Ltd (CN)
NSE:ENDURANCE
|
IN |
|
S
|
Siili Solutions Oyj
LSE:0RFO
|
FI |
|
Dr. Lal PathLabs Ltd
BSE:539524
|
IN |
|
S
|
San Miguel Corp
OTC:SMGBF
|
PH |
|
Field Trip Health Ltd
TSX:FTRP
|
CA |
Balance Sheet
Balance Sheet Decomposition
LG CNS Co Ltd
LG CNS Co Ltd
Balance Sheet Decomposition is not available for
LG CNS Co Ltd
LG CNS Co Ltd
Balance Sheet
LG CNS Co Ltd
LG CNS Co Ltd
Currency: KRW
| Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
728 349
|
504 568
|
1 076 592
|
1 140 988
|
|
| Cash |
6
|
6
|
6
|
6
|
|
| Cash Equivalents |
728 343
|
504 562
|
1 076 586
|
1 140 982
|
|
| Short-Term Investments |
122 702
|
166 668
|
87 700
|
538 797
|
|
| Total Receivables |
1 814 658
|
2 152 548
|
2 059 930
|
2 058 875
|
|
| Accounts Receivables |
1 783 875
|
2 106 954
|
2 001 684
|
2 005 715
|
|
| Other Receivables |
30 783
|
45 594
|
58 246
|
53 159
|
|
| Inventory |
55 359
|
66 498
|
45 921
|
60 638
|
|
| Other Current Assets |
126 871
|
146 950
|
165 173
|
165 666
|
|
| Total Current Assets |
2 847 939
|
3 037 232
|
3 435 316
|
3 964 963
|
|
| PP&E Net |
628 419
|
607 453
|
667 291
|
886 500
|
|
| PP&E Gross |
628 419
|
607 453
|
667 291
|
886 500
|
|
| Accumulated Depreciation |
552 036
|
560 863
|
596 296
|
653 294
|
|
| Intangible Assets |
97 138
|
80 707
|
55 875
|
44 952
|
|
| Goodwill |
7 347
|
7 347
|
7 816
|
7 816
|
|
| Note Receivable |
25 819
|
26 074
|
18 429
|
12 885
|
|
| Long-Term Investments |
178 081
|
190 243
|
207 944
|
256 998
|
|
| Other Long-Term Assets |
80 391
|
91 623
|
111 837
|
111 161
|
|
| Other Assets |
7 347
|
7 347
|
7 816
|
7 816
|
|
| Total Assets |
3 865 135
N/A
|
4 040 680
+5%
|
4 504 508
+11%
|
5 285 275
+17%
|
|
| Liabilities | |||||
| Accounts Payable |
740 394
|
768 321
|
794 053
|
664 284
|
|
| Accrued Liabilities |
82 657
|
70 599
|
78 862
|
80 621
|
|
| Short-Term Debt |
276 537
|
2 565
|
5 515
|
0
|
|
| Current Portion of Long-Term Debt |
274 328
|
15 978
|
201 733
|
333 063
|
|
| Other Current Liabilities |
631 419
|
685 649
|
772 161
|
782 854
|
|
| Total Current Liabilities |
2 005 335
|
1 543 113
|
1 852 324
|
1 860 821
|
|
| Long-Term Debt |
196 202
|
590 892
|
486 483
|
438 656
|
|
| Deferred Income Tax |
5 547
|
5 354
|
7 322
|
7 980
|
|
| Minority Interest |
4 823
|
4 951
|
7 694
|
8 688
|
|
| Other Liabilities |
27 263
|
33 065
|
35 567
|
36 379
|
|
| Total Liabilities |
2 239 169
N/A
|
2 177 374
-3%
|
2 389 391
+10%
|
2 352 525
-2%
|
|
| Equity | |||||
| Common Stock |
47 198
|
47 198
|
47 198
|
52 043
|
|
| Retained Earnings |
1 553 012
|
1 772 366
|
2 003 112
|
2 220 617
|
|
| Additional Paid In Capital |
34 586
|
34 586
|
34 586
|
623 636
|
|
| Unrealized Security Profit/Loss |
9 088
|
5 619
|
5 722
|
9 274
|
|
| Other Equity |
257
|
3 535
|
24 497
|
27 180
|
|
| Total Equity |
1 625 966
N/A
|
1 863 306
+15%
|
2 115 116
+14%
|
2 932 751
+39%
|
|
| Total Liabilities & Equity |
3 865 135
N/A
|
4 040 680
+5%
|
4 504 508
+11%
|
5 285 275
+17%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
97
|
97
|
97
|
97
|
|
Switch to:
Switch to:
See Also
Discover More
